Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia

ABSTRACT: Objective: To evaluate the aspirin resistance prevalence in patients with previous ischemic cerebrovascular disease undergoing aspirin therapy for secondary prevention. Materials and methods: Three hundred fifty patients presenting ischemic strokes and 100 healthy controls under aspirin tr...

Full description

Autores:
Bedoya Berrío, Gabriel de Jesús
Román González, Alejandro
Naranjo González, Carlos Andrés
Cardona Maya, Walter Darío
Vallejo, Dionis
García, Francisco
Franco, Cesar
Álvarez Pelaéz, María Leonor
Tobón Acosta, Luis Ignacio
López, Marta Ibeth
Rúa Molina, Diana Carolina
Cadavid Jaramillo, Ángela Patricia
Torres Hernández, José Domingo
Tipo de recurso:
Article of investigation
Fecha de publicación:
2021
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/41097
Acceso en línea:
https://hdl.handle.net/10495/41097
Palabra clave:
Aspirina
Aspirin
Accidente Cerebrovascular Isquémico
Ischemic Stroke
Colombia
Resistencia a Medicamentos
Drug Resistance
Agregación Plaquetaria
Platelet Aggregation
https://id.nlm.nih.gov/mesh/D001241
https://id.nlm.nih.gov/mesh/D000083242
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D004351
https://id.nlm.nih.gov/mesh/D010974
Rights
openAccess
License
http://creativecommons.org/licenses/by/2.5/co/
id UDEA2_57ec4ef5d9bbbfdcfeb0da807420a467
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/41097
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia
title Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia
spellingShingle Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia
Aspirina
Aspirin
Accidente Cerebrovascular Isquémico
Ischemic Stroke
Colombia
Resistencia a Medicamentos
Drug Resistance
Agregación Plaquetaria
Platelet Aggregation
https://id.nlm.nih.gov/mesh/D001241
https://id.nlm.nih.gov/mesh/D000083242
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D004351
https://id.nlm.nih.gov/mesh/D010974
title_short Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia
title_full Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia
title_fullStr Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia
title_full_unstemmed Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia
title_sort Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia
dc.creator.fl_str_mv Bedoya Berrío, Gabriel de Jesús
Román González, Alejandro
Naranjo González, Carlos Andrés
Cardona Maya, Walter Darío
Vallejo, Dionis
García, Francisco
Franco, Cesar
Álvarez Pelaéz, María Leonor
Tobón Acosta, Luis Ignacio
López, Marta Ibeth
Rúa Molina, Diana Carolina
Cadavid Jaramillo, Ángela Patricia
Torres Hernández, José Domingo
dc.contributor.author.none.fl_str_mv Bedoya Berrío, Gabriel de Jesús
Román González, Alejandro
Naranjo González, Carlos Andrés
Cardona Maya, Walter Darío
Vallejo, Dionis
García, Francisco
Franco, Cesar
Álvarez Pelaéz, María Leonor
Tobón Acosta, Luis Ignacio
López, Marta Ibeth
Rúa Molina, Diana Carolina
Cadavid Jaramillo, Ángela Patricia
Torres Hernández, José Domingo
dc.contributor.researchgroup.spa.fl_str_mv Genética Molecular (GENMOL)
Grupo de Investigación en Trombosis
Grupo Reproducción
dc.subject.decs.none.fl_str_mv Aspirina
Aspirin
Accidente Cerebrovascular Isquémico
Ischemic Stroke
Colombia
Resistencia a Medicamentos
Drug Resistance
Agregación Plaquetaria
Platelet Aggregation
topic Aspirina
Aspirin
Accidente Cerebrovascular Isquémico
Ischemic Stroke
Colombia
Resistencia a Medicamentos
Drug Resistance
Agregación Plaquetaria
Platelet Aggregation
https://id.nlm.nih.gov/mesh/D001241
https://id.nlm.nih.gov/mesh/D000083242
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D004351
https://id.nlm.nih.gov/mesh/D010974
dc.subject.meshuri.none.fl_str_mv https://id.nlm.nih.gov/mesh/D001241
https://id.nlm.nih.gov/mesh/D000083242
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D004351
https://id.nlm.nih.gov/mesh/D010974
description ABSTRACT: Objective: To evaluate the aspirin resistance prevalence in patients with previous ischemic cerebrovascular disease undergoing aspirin therapy for secondary prevention. Materials and methods: Three hundred fifty patients presenting ischemic strokes and 100 healthy controls under aspirin treatment were evaluated using the optic platelet aggregation test. Results: Aspirin resistance was found in 7.4% of the patients with ischemic stroke and 4% of controls. Aspirin resistance was associated with stroke recurrence in univariate analysis (p = 0.004). Aspirin resistance was not associated with smoking, diabetes, or hypercholesterolemia. Conclusion: Aspirin resistance is present in Colombian patients with ischemic stroke as well as in healthy controls.
publishDate 2021
dc.date.issued.none.fl_str_mv 2021
dc.date.accessioned.none.fl_str_mv 2024-08-11T20:16:04Z
dc.date.available.none.fl_str_mv 2024-08-11T20:16:04Z
dc.type.spa.fl_str_mv Artículo de investigación
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Roman-Gonzalez A, Naranjo CA, Cardona-Maya WD, Vallejo D, Garcia F, Franco C, Alvarez L, Tobón LI, López MI, Rua C, Bedoya G, Cadavid Á, Torres JD. Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia. Stroke Res Treat. 2021 May 21;2021:9924710. doi: 10.1155/2021/9924710.
dc.identifier.issn.none.fl_str_mv 2090-8105
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/41097
dc.identifier.doi.none.fl_str_mv 10.1155/2021/9924710
dc.identifier.eissn.none.fl_str_mv 2042-0056
identifier_str_mv Roman-Gonzalez A, Naranjo CA, Cardona-Maya WD, Vallejo D, Garcia F, Franco C, Alvarez L, Tobón LI, López MI, Rua C, Bedoya G, Cadavid Á, Torres JD. Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia. Stroke Res Treat. 2021 May 21;2021:9924710. doi: 10.1155/2021/9924710.
2090-8105
10.1155/2021/9924710
2042-0056
url https://hdl.handle.net/10495/41097
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Stroke. Res. Treat.
dc.relation.citationendpage.spa.fl_str_mv 5
dc.relation.citationstartpage.spa.fl_str_mv 1
dc.relation.citationvolume.spa.fl_str_mv 2021
dc.relation.ispartofjournal.spa.fl_str_mv Stroke Research and Treatment
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by/2.5/co/
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv http://creativecommons.org/licenses/by/2.5/co/
https://creativecommons.org/licenses/by/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 5 páginas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Hindawi
Wiley Open Access
dc.publisher.place.spa.fl_str_mv Nueva York, Estados Unidos
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/f21fba47-e12b-476d-b19b-9d396cc8f709/download
https://bibliotecadigital.udea.edu.co/bitstreams/83160b23-1c0c-485b-aaec-824502f73472/download
https://bibliotecadigital.udea.edu.co/bitstreams/c555caba-41d6-40dd-bc37-772de33241ff/download
https://bibliotecadigital.udea.edu.co/bitstreams/e501ad28-558d-4fa5-adef-e44a9a4cc55b/download
https://bibliotecadigital.udea.edu.co/bitstreams/084baa4d-c3cc-4021-a482-45c9eaacbebb/download
bitstream.checksum.fl_str_mv 1646d1f6b96dbbbc38035efc9239ac9c
8a4605be74aa9ea9d79846c1fba20a33
655e9bf85d2eaf75d3ad6ea3325a368f
5bb0f2c294c66c5c7ee89aead756b03e
f49e075bfa62ed52fdd96d278967d047
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052367366062080
spelling Bedoya Berrío, Gabriel de JesúsRomán González, AlejandroNaranjo González, Carlos AndrésCardona Maya, Walter DaríoVallejo, DionisGarcía, FranciscoFranco, CesarÁlvarez Pelaéz, María LeonorTobón Acosta, Luis IgnacioLópez, Marta IbethRúa Molina, Diana CarolinaCadavid Jaramillo, Ángela PatriciaTorres Hernández, José DomingoGenética Molecular (GENMOL)Grupo de Investigación en TrombosisGrupo Reproducción2024-08-11T20:16:04Z2024-08-11T20:16:04Z2021Roman-Gonzalez A, Naranjo CA, Cardona-Maya WD, Vallejo D, Garcia F, Franco C, Alvarez L, Tobón LI, López MI, Rua C, Bedoya G, Cadavid Á, Torres JD. Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from Colombia. Stroke Res Treat. 2021 May 21;2021:9924710. doi: 10.1155/2021/9924710.2090-8105https://hdl.handle.net/10495/4109710.1155/2021/99247102042-0056ABSTRACT: Objective: To evaluate the aspirin resistance prevalence in patients with previous ischemic cerebrovascular disease undergoing aspirin therapy for secondary prevention. Materials and methods: Three hundred fifty patients presenting ischemic strokes and 100 healthy controls under aspirin treatment were evaluated using the optic platelet aggregation test. Results: Aspirin resistance was found in 7.4% of the patients with ischemic stroke and 4% of controls. Aspirin resistance was associated with stroke recurrence in univariate analysis (p = 0.004). Aspirin resistance was not associated with smoking, diabetes, or hypercholesterolemia. Conclusion: Aspirin resistance is present in Colombian patients with ischemic stroke as well as in healthy controls.Universidad de Antioquia. Vicerrectoría de investigación. Comité para el Desarrollo de la Investigación - CODIColombia. Ministerio de Ciencia, Tecnología e Innovación - MincienciasCOL0006723COL0010421COL00076315 páginasapplication/pdfengHindawiWiley Open AccessNueva York, Estados Unidoshttp://creativecommons.org/licenses/by/2.5/co/https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Frequency of Aspirin Resistance in Ischemic Stroke Patients and Healthy Controls from ColombiaArtículo de investigaciónhttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARThttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAspirinaAspirinAccidente Cerebrovascular IsquémicoIschemic StrokeColombiaResistencia a MedicamentosDrug ResistanceAgregación PlaquetariaPlatelet Aggregationhttps://id.nlm.nih.gov/mesh/D001241https://id.nlm.nih.gov/mesh/D000083242https://id.nlm.nih.gov/mesh/D003105https://id.nlm.nih.gov/mesh/D004351https://id.nlm.nih.gov/mesh/D010974Stroke. Res. Treat.512021Stroke Research and Treatment1115-04-18130RoR:03bp5hc83RoR:03fd5ne08PublicationCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8927https://bibliotecadigital.udea.edu.co/bitstreams/f21fba47-e12b-476d-b19b-9d396cc8f709/download1646d1f6b96dbbbc38035efc9239ac9cMD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/83160b23-1c0c-485b-aaec-824502f73472/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADORIGINALBedoyaGabriel_2021_Aspirin_Resistance_Ischemic.pdfBedoyaGabriel_2021_Aspirin_Resistance_Ischemic.pdfArtículo de investigaciónapplication/pdf363813https://bibliotecadigital.udea.edu.co/bitstreams/c555caba-41d6-40dd-bc37-772de33241ff/download655e9bf85d2eaf75d3ad6ea3325a368fMD51trueAnonymousREADTEXTBedoyaGabriel_2021_Aspirin_Resistance_Ischemic.pdf.txtBedoyaGabriel_2021_Aspirin_Resistance_Ischemic.pdf.txtExtracted texttext/plain24391https://bibliotecadigital.udea.edu.co/bitstreams/e501ad28-558d-4fa5-adef-e44a9a4cc55b/download5bb0f2c294c66c5c7ee89aead756b03eMD54falseAnonymousREADTHUMBNAILBedoyaGabriel_2021_Aspirin_Resistance_Ischemic.pdf.jpgBedoyaGabriel_2021_Aspirin_Resistance_Ischemic.pdf.jpgGenerated Thumbnailimage/jpeg13704https://bibliotecadigital.udea.edu.co/bitstreams/084baa4d-c3cc-4021-a482-45c9eaacbebb/downloadf49e075bfa62ed52fdd96d278967d047MD55falseAnonymousREAD10495/41097oai:bibliotecadigital.udea.edu.co:10495/410972025-03-26 21:12:23.384http://creativecommons.org/licenses/by/2.5/co/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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